Image-Guided Transarterial Chemoembolization With Drug-Eluting Beads Loaded with Doxorubicin (DEBDOX) for Unresectable Hepatic Metastases from Melanoma: Technique and Outcomes

Image-Guided Transarterial Chemoembolization With Drug-Eluting Beads Loaded with Doxorubicin... Cardiovasc Intervent Radiol (2017) 40:1392–1400 DOI 10.1007/s00270-017-1651-z CLINICAL INVESTIGATION INTERVENTIONAL ONCOLOGY Image-Guided Transarterial Chemoembolization With Drug-Eluting Beads Loaded with Doxorubicin (DEBDOX) for Unresectable Hepatic Metastases from Melanoma: Technique and Outcomes 1 2 3 4 4 • • • • • Jack Rostas Alda Tam Takami Sato Larry Kelly Cliff Tatum 1 1 1 • • Charles Scoggins Kelly McMasters Robert C. G. Martin II Received: 15 December 2016 / Accepted: 4 April 2017 / Published online: 15 May 2017 Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2017 Abstract Results Twenty patients received a total of 61 DEBDOX Purpose Hepatic metastasis from melanoma represents a treatments from January 2010 to March 2013. The median therapeutic dilemma, with limited effective options for the hepatic tumor burden was 40% (range 20–55), 18 patients 85% of cases deemed unresectable. Systemic agents confer (90%) had bilobar disease, and 13 patients (65%) had toxicity and, along with traditional local hepatic arterial- concomitant extrahepatic disease. At median assessment of directed therapies such as transarterial chemoembolization, 2.5 months, 11 patients (55%) exhibited a tumor response have not led to a significant increase in survival. The aim of and 16 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png CardioVascular and Interventional Radiology Springer Journals

Image-Guided Transarterial Chemoembolization With Drug-Eluting Beads Loaded with Doxorubicin (DEBDOX) for Unresectable Hepatic Metastases from Melanoma: Technique and Outcomes

Loading next page...
 
/lp/springer_journal/image-guided-transarterial-chemoembolization-with-drug-eluting-beads-EMGBV3q8LZ
Publisher
Springer US
Copyright
Copyright © 2017 by Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE)
Subject
Medicine & Public Health; Imaging / Radiology; Cardiology; Nuclear Medicine; Ultrasound
ISSN
0174-1551
eISSN
1432-086X
D.O.I.
10.1007/s00270-017-1651-z
Publisher site
See Article on Publisher Site

Abstract

Cardiovasc Intervent Radiol (2017) 40:1392–1400 DOI 10.1007/s00270-017-1651-z CLINICAL INVESTIGATION INTERVENTIONAL ONCOLOGY Image-Guided Transarterial Chemoembolization With Drug-Eluting Beads Loaded with Doxorubicin (DEBDOX) for Unresectable Hepatic Metastases from Melanoma: Technique and Outcomes 1 2 3 4 4 • • • • • Jack Rostas Alda Tam Takami Sato Larry Kelly Cliff Tatum 1 1 1 • • Charles Scoggins Kelly McMasters Robert C. G. Martin II Received: 15 December 2016 / Accepted: 4 April 2017 / Published online: 15 May 2017 Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2017 Abstract Results Twenty patients received a total of 61 DEBDOX Purpose Hepatic metastasis from melanoma represents a treatments from January 2010 to March 2013. The median therapeutic dilemma, with limited effective options for the hepatic tumor burden was 40% (range 20–55), 18 patients 85% of cases deemed unresectable. Systemic agents confer (90%) had bilobar disease, and 13 patients (65%) had toxicity and, along with traditional local hepatic arterial- concomitant extrahepatic disease. At median assessment of directed therapies such as transarterial chemoembolization, 2.5 months, 11 patients (55%) exhibited a tumor response have not led to a significant increase in survival. The aim of and 16

Journal

CardioVascular and Interventional RadiologySpringer Journals

Published: May 15, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off